Fubon Financial Holding Co (富邦金控) yesterday said that its insurance unit would weather rising COVID-19 insurance claims and no fundraising is needed.
Fubon Insurance Co (富邦產險) said it has sold about 2.31 million COVID-19 insurance policies and as of the middle of this month had paid NT$1.1 billion (US$37.09 million) of claims from 29,000 policyholders.
It pays a total of NT$50 million per day in claims, it said.
Photo: CNA
It is difficult to calculate how much more compensation it would have to pay, as local COVID-19 infections are still on the rise, with a peak not expected until next month, Fubon Insurance said.
Fubon Insurance reiterated that it would not avoid its responsibility to policyholders.
“Fubon Insurance has net value of NT$30 billion to NT$40 billion, and assets of NT$130 billion, not to mention the high net value of Fubon Financial,” Fubon Financial president Jerry Harn (韓蔚廷) told an investors’ conference amid speculation that the company would be unable to bear the burden.
Policyholders would receive compensation, Harn said.
The loss rate on COVID-19 insurance policies was about 15 percent, the company said.
Three factors would affect the figure, including the ultimate number of local infections, the government’s virus policy and clarification of disputes, it said.
If the financial pressure becomes too heavy, Fubon Insurance would consider applying to the Financial Supervisory Commission (FSC) to use part of its special reserve to write off losses, it said.
The insurer can allocate as much as NT$15.5 billion, it said.
Fubon Financial Holding reported an annual decline of 9.4 percent in net profit to NT$46.5 billion for the first quarter, mainly because of a drop of 7 percent in net profit at Fubon Life Insurance Co (富邦人壽) to NT$36.4 billion amid decreasing first-year premiums and lower returns on investments, corporate data showed.
Realized capital gains from fixed-income investments plunged about 75 percent year-on-year to NT$6.7 billion in the first quarter, the data showed.
In related news, China Life Insurance Co (中國人壽) yesterday announced that even though its insurance terms do not stipulate that it must compensate policyholders who catch COVID-19, but are not hospitalized due to the virus, it would pay those who stay home as much as it pays for hospitalizations, as long as they are prescribed drugs.
The drugs are not limited to oral antivirus drugs such as Paxlovid and molnupiravir, or a traditional Chinese compound called Taiwan Chingguan Yihau (清冠一號), or NRICM101, but policyholders should provide prescriptions, a doctor’s diagnosis and a digital COVID-19 certificate with their claims, China Life said.
The FSC has said that insurance firms can decide themselves — while adhering to the terms of their policies — whether to compensate people who catch COVID-19, but are not hospitalized.
SEMICONDUCTOR SERVICES: A company executive said that Taiwanese firms must think about how to participate in global supply chains and lift their competitiveness Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) yesterday said it expects to launch its first multifunctional service center in Pingtung County in the middle of 2027, in a bid to foster a resilient high-tech facility construction ecosystem. TSMC broached the idea of creating a center two or three years ago when it started building new manufacturing capacity in the US and Japan, the company said. The center, dubbed an “ecosystem park,” would assist local manufacturing facility construction partners to upgrade their capabilities and secure more deals from other global chipmakers such as Intel Corp, Micron Technology Inc and Infineon Technologies AG, TSMC said. It
People walk past advertising for a Syensqo chip at the Semicon Taiwan exhibition in Taipei yesterday.
NO BREAKTHROUGH? More substantial ‘deliverables,’ such as tariff reductions, would likely be saved for a meeting between Trump and Xi later this year, a trade expert said China launched two probes targeting the US semiconductor sector on Saturday ahead of talks between the two nations in Spain this week on trade, national security and the ownership of social media platform TikTok. China’s Ministry of Commerce announced an anti-dumping investigation into certain analog integrated circuits (ICs) imported from the US. The investigation is to target some commodity interface ICs and gate driver ICs, which are commonly made by US companies such as Texas Instruments Inc and ON Semiconductor Corp. The ministry also announced an anti-discrimination probe into US measures against China’s chip sector. US measures such as export curbs and tariffs
The US on Friday penalized two Chinese firms that acquired US chipmaking equipment for China’s top chipmaker, Semiconductor Manufacturing International Corp (SMIC, 中芯國際), including them among 32 entities that were added to the US Department of Commerce’s restricted trade list, a US government posting showed. Twenty-three of the 32 are in China. GMC Semiconductor Technology (Wuxi) Co (吉姆西半導體科技) and Jicun Semiconductor Technology (Shanghai) Co (吉存半導體科技) were placed on the list, formally known as the Entity List, for acquiring equipment for SMIC Northern Integrated Circuit Manufacturing (Beijing) Corp (中芯北方積體電路) and Semiconductor Manufacturing International (Beijing) Corp (中芯北京), the US Federal Register posting said. The
RSS